297 related articles for article (PubMed ID: 8091904)
1. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
[TBL] [Abstract][Full Text] [Related]
2. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
Ko EC; Jhala NC; Shultz JJ; Chhieng DC
Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
[TBL] [Abstract][Full Text] [Related]
3. Moc-31, fibronectin and CEA in the differential diagnosis of malignant effusions: an immunocytochemical study.
Athanassiadou P; Gonidi M; Liossi A; Petrakakou E; Nakopoulou L; Zerva C; Athanassiades P
Pathol Oncol Res; 2000; 6(2):100-3. PubMed ID: 10936783
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of the expression of CEA and a myelomonocytic antigen (CD15) in serous effusions using two monoclonal antibodies NEO 723 and Leu M1].
Daste G; Berthier F; Mauduyt MA; Soleilhavoup JP
Arch Anat Cytol Pathol; 1992; 40(4):183-9. PubMed ID: 1294046
[TBL] [Abstract][Full Text] [Related]
5. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
[TBL] [Abstract][Full Text] [Related]
6. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
8. Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions.
Sehested M; Ralfkjaer E; Rasmussen J
Acta Cytol; 1983; 27(2):124-7. PubMed ID: 6340401
[TBL] [Abstract][Full Text] [Related]
9. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
10. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
11. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
12. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
13. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of p53 protein in the study of serous effusions.
Zoppi JA; Pellicer EM; Sundblad AS
Acta Cytol; 1995; 39(4):721-4. PubMed ID: 7631546
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP
Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202
[TBL] [Abstract][Full Text] [Related]
17. [Carcinoembryonic antigen in ascites and pleural effusions].
Lirzin P; Zeitoun P; Vandromme L; Salas H
Gastroenterol Clin Biol; 1984 Mar; 8(3):222-7. PubMed ID: 6714557
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
[TBL] [Abstract][Full Text] [Related]
19. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].
Gulyás M; Elek G; Molnár M; Szollár L
Orv Hetil; 1995 Nov; 136(45):2453-8. PubMed ID: 8524550
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]